Locations
Bern, Switzerland · Bern, Switzerland
industry
Software
Size
11-50 employees
Stage
Series B
founded in
2017
RetinAI is a Swiss and US-based software company improving and supporting R&D of first-in-human drug candidates, supercharging management and oversight of clinical trials, and enabling the research needed to elevate the quality of care for patients with eye diseases. We achieve this goal by building tools to collect, analyze, and organize health data. Our fundamental belief is that in the future, every patient will use drugs alongside a digital application that will enable them and their physicians to better assess the right drug, in the right amount, and the right frequency for patients.
Something looks off?On-site & Remote